SC 13D Filing

Company

Protalix BioTherapeutics, Inc.

Filed

September 3, 1999

Accession Number

0000950170-99-001401

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →